申请人:Hangzhou DAC Biotech Co., Ltd.
公开号:US10836796B2
公开(公告)日:2020-11-17
The present invention is related to novel cytotoxic agents, derivatives of Amanita toxins of Formula (I), wherein , -----, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, L, m, n and Q are defined herein, the preparation and the therapeutic uses in the targeted treatment of cancers, autoimmune disorders, and infectious diseases.
本发明涉及新型细胞毒剂、式 (I) 的天南星毒素衍生物,其中 , -----, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, L, m, n 和 Q 在此定义,制备方法以及在癌症、自身免疫性疾病和传染性疾病靶向治疗中的治疗用途。